Cancer Biology and Therapy

Published by: Taylor & Francis Group  

People

  1. Kolesnick
    Kolesnick
  2. Fuks
    Fuks
  3. Ling
    Ling
  4. Adusumilli
    Adusumilli
  5. Chen
    Chen
  6. D'Angelo
    D'Angelo
  7. Haimovitz-Friedman
    Haimovitz-Friedman
  8. Hanrahan
    Hanrahan
  9. Heller
    Heller
  10. Jhanwar
    Jhanwar

Groups

  1. Department of Medicine (14)
  2. GSK Faculty (11)
  3. Solid Tumor Oncology Division (9)
  4. Molecular Pharmacology and Chemistry Program Faculty (6)
  5. Sloan Kettering Institute Faculty (6)
  6. Sloan Kettering Institute Postdocs (6)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  8. Division of Subspecialty Medicine (3)
  9. Endocrinology (3)
  10. Hematologic Malignancies, Division of (3)
Search Within
  1. "Taylor & Francis Group"
Formats
  1. Journal Article (27)
  2. Review (1)
Groups
  1. Department of Medicine (14)
  2. GSK Faculty (11)
  3. Solid Tumor Oncology Division (9)
  4. Molecular Pharmacology and Chemistry Program Faculty (6)
  5. Sloan Kettering Institute Faculty (6)
  6. Sloan Kettering Institute Postdocs (6)

More Groups

People
  1. James Russell (3)
  2. Richard Kolesnick (3)
  3. Anthony Mato (2)
  4. C Ling (2)
  5. Juan Antonio Diaz Gonzalez (2)
  6. Xiao-Feng Li (2)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2019 (1)
  4. 2018 (1)
  5. 2014 (1)
  6. 2013 (1)

More Years

Publishers
  1. Taylor & Francis Group (28)

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma
    Journal Article

    Kubala, J. M.; Laursen, K. B.; Schreiner, R.; Williams, R. M.; van der Mijn, J. C.; Crowley, M. J.; Mongan, N. P.; Nanus, D. M.; Heller, D. A.; Gudas, L. J.
    Cancer Biology and Therapy (2023)

    Fulltext@MSK | Save
  • Multimodality therapy in metastatic pancreas cancer with a BRCA mutation and durable long-term outcome: Biology, intervention, or both?
    Review

    Sutton, T. L.; Grossberg, A.; Ey, F.; O’Reilly, E. M.; Sheppard, B. C.
    Cancer Biology and Therapy (2021)

    Fulltext@MSK | Save
  • Management of giant cell hepatitis associated with chronic lymphocytic leukemia - A case series and review of the literature
    Journal Article

    Rhodes, J. M.; Schuster, S. J.; Furth, E. E.; Kennard, K.; Nasta, S. D.; Svoboda, J.; Porter, D. L.; Mato, A. R.
    Cancer Biology and Therapy (2019)

    Fulltext@MSK | Save
  • Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies
    Journal Article

    Mato, A. R.; Samp, J. C.; Gauthier, G.; Terasawa, E.; Brander, D. M.
    Cancer Biology and Therapy (2018)

    Fulltext@MSK | Save
  • Anti-EGFR therapeutic efficacy correlates directly with inhibition of STAT3 activity
    Journal Article

    Ung, N.; Putoczki, T. L.; Stylli, S. S.; Ng, I.; Mariadason, J. M.; Chan, T. A.; Zhu, H. J.; Luwor, R. B.
    Cancer Biology and Therapy (2014)

    Fulltext@MSK | Save
  • The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines
    Journal Article

    Mendonça-Torres, M. C.; Roberts, S. S.
    Cancer Biology and Therapy (2013)

    Fulltext@MSK | Save
  • Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia
    Journal Article

    Karar, J.; Cerniglia, G. J.; Lindsten, T.; Koumenis, C.; Maity, A.
    Cancer Biology and Therapy (2012)

    Fulltext@MSK | Save
  • Are DNA methylation markers ready for colorectal cancer detection?
    Journal Article

    De Paoli, V. M.; Chen, C. H.; Cheng, Y. W.
    Cancer Biology and Therapy (2010)

    Fulltext@MSK | Save
  • The molecular pathogenesis of small cell lung cancer
    Journal Article

    D'Angelo, S. P.; Pietanza, M. C.
    Cancer Biology and Therapy (2010)

    Fulltext@MSK | Save
  • An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo
    Journal Article

    Cherrin, C.; Haskell, K.; Howell, B.; Jones, R.; Leander, K.; Robinson, R.; Watkins, A.; Bilodeau, M.; Hoffman, J.; Sanderson, P.; more...
    Cancer Biology and Therapy (2010)

    Fulltext@MSK | Save

    • Cancer Biology and Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Biology & Therapy 1538-4047 Landes Bioscience
    Cancer Biology & Therapy 1538-4047 Taylor & Francis Group
    Cancer biology & therapy 1555-8576 Landes Bioscience
    Cancer biology & therapy 15558576 Unknown
    Cancer Biology and Therapy 1538-4047 Taylor & Francis Group
    Cancer Biology and Therapy 1538-4047 Taylor & Francis Group
    Cancer Biology and Therapy 1538-4047 Taylor & Francis Group
    Cancer Biology and Therapy 15558576 Landes Bioscience
    Cancer Biology and Therapy 15384047 Unknown
    Cancer Biology and Therapy 1555-8576 Landes Bioscience
    Cancer Biology and Therapy 15384047 2019, © 2019 Taylor & Francis Group, Llc
    Cancer Biology and Therapy 15384047 Landes Bioscience